Support Us!

Cervical Cancer Treatment

When determining the stage of the cancer, doctors analyze the size of the cancer or how far it has spread. This is utilized in order to plan and monitor the treatment process. There are many different ways to treat cervical cancer. These include:

  • Surgery: Doctors cut out the cancer
  • Chemotherapy: Utilizing specalized medicine to kill the cancer or reduce its size. These drugs can either be ingested by pill or inserted via vein and sometimes both ways are used
  • Radiation therapy: Using high-energy rays in order to kill the cancer cells (similar to x-rays)
  • Immunotherapy: Works together with your body’s immune system to block the growth and spread of cancer cells. This works to control side effects from other treatments and/or kill cancer cells 
  • Targeted therapy: Using drugs to block the growth and spread of cancer cells. Similar to chemotherapy, these drugs can either be ingested or injected in the vein or both. Testing is done to see if targeted therapy is correct for you. 

Accordance with the CDC: https://www.cdc.gov/cervical-cancer/treatment/index.html#:~:text=Cervical%20cancer%20can%20be%20treated,referred%20to%20a%20gynecologic%20oncologist. 

Cervical cancer treatment breakthrough cuts risk of death by 40%


Read here: https://news.cancerresearchuk.org/2024/10/14/cervical-cancer-treatment-chemotherapy-cuts-risk-of-death-by-40-percent-interlace/ 

Researchers funded by Cancer Research UK have discovered a major improvement in cervical cancer treatment by modifying how existing chemotherapy drugs are used. The INTERLACE trial found that adding a short six-week course of induction chemotherapy before the standard chemoradiation (CRT) reduces the risk of death by 40% and lowers the chance of cancer returning by 35%. The study showed that after five years, 80% of patients who received induction chemotherapy before CRT were alive, compared to 72% of those who only received standard treatment. Additionally, 73% of those in the new treatment group had not seen their cancer return, compared to 64% in the standard group. Because the drugs used are already approved, affordable, and widely available, experts believe this approach could quickly become a new standard of care. Researchers also suggest that this method could improve treatment outcomes for other types of cancer.